Japan's Astellas announces partnership with Korea Institute of Startup and Entrepreneurship Development

Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...

July 17, 2025 | Thursday | News
Gero’s ProtoBind‑Diff redefines drug discovery by designing molecules from sequence alone

BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...

July 2, 2025 | Wednesday | Opinion
SK Biosciences partners with PhnyX Lab to streamline drug discovery research using AI

South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation PhnyX Lab in ...

June 27, 2025 | Friday | News
Nuclera and Cytiva team up to accelerate characterisation of proteins for drug development

Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...

May 30, 2025 | Friday | News
China's Viva Biotech launches new AI-driven drug discovery platform

China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...

May 16, 2025 | Friday | News
HistoIndex secures S$9 Million investment to drive next phase of expansion in digital pathology in Singapore

HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader...

May 2, 2025 | Friday | News
Singapore deepens research collaboration in applied AI for drug discovery and life sciences

A*STAR and ETH Zürich have officially inked a Memorandum of Understanding (MOU) to deepen research collaboration in...

April 28, 2025 | Monday | News
Japan's Ono collaborates with Jorna Therapeutics to generate novel RNA editing therapeutics

Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with US-based startup Jorna The...

April 22, 2025 | Tuesday | News
Japan's PRISM BioLab and Elix join forces to accelerate AI-driven drug discovery

Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...

April 14, 2025 | Monday | News
Engine Biosciences and Experimental Drug Development Centre partner to advance cancer therapies

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medic...

April 8, 2025 | Tuesday | News
HiRO and Hallym University Sacred Heart Hospital to advance drug development in Korea

Harvest Integrated Research Organization (HiRO), a boutique global CRO, has signed an Memorandum of Understanding (MoU) ...

March 21, 2025 | Friday | News
Insilico Medicine secures $110 M Series E financing to advance AI-driven drug discovery innovation

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...

March 13, 2025 | Thursday | News
Korean firm LG to develop AI model for protein multistate structure prediction

LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...

February 9, 2025 | Sunday | News
Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351

Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...

January 31, 2025 | Friday | News
“There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis”

What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...

February 1, 2025 | Saturday | Opinion
APAC takes centre-stage in AI-driven drug discovery

Drug discovery is a lengthy and costly process, typically requiring billions of dollars and nearly a decade to bring a d...

February 1, 2025 | Saturday | Analysis
GHIT announces $12.7 M worth investment for developing diagnostics and drugs for malaria, NTDs

The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...

January 31, 2025 | Friday | News
Japan's ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research

Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...

January 29, 2025 | Wednesday | News